GMP Medicine Sodium Chloride Infusion 0.9% 200ml

Name: GMP Medicine Sodium Chloride Infusion 0.9% 200ml
Brand: Qingdao Hiseeking Enterprises Co., Ltd.
SKU: 938362485

Shandong, ChinaQingdao Hiseeking Enterprises Co., Ltd.

Negotiable

20,000 bottles

Product profile

Model NO.

0.9% 200ml

Company profile

Qingdao Hiseeking Enterprises Co., Ltd.

Shandong, China

Business Type: Trading CompanyExport Year: 2007-08-01Nearest Port: QINGDAO PORTAverage Response Time: >24hTerms of Payment: LC, T/TInternational Commercial Terms(Incoterms): FOB, CFR, CIF

AI-Powered supplier vetting

SummaryQingdao Hiseeking Enterprises Co., Ltd. is a China-based trading company headquartered in Qingdao, Shandong, focused on pharmaceutical products including medicines, capsules, tablets, injections, and other dosage forms. The supplier states that it has an organized production base certified by GMP, ISO, and HACCP, and reports exporting since 2007 with 90% of sales from exports and self-operated import and export rights. It offers OEM registration under its QHSK or customer brands and serves markets in South America, the Middle East, Eastern Asia, and Africa. Evidence supports pharmaceutical product coverage, export experience, production-related certifications, and customization through OEM. However, the provided information does not establish after-sales procedures, financial strength, innovation achievements, or a broad verified customer-case history. Trade records show one transaction each for Azitromicina and Cloranfenicol involving Bolivia.

Supplier typeThe supplier is identified as a trading company, legally named Qingdao Hiseeking Enterprises Co., Ltd., operating from Shibei District, Qingdao, China. It is described as involved in pharmaceutical manufacturing and exporting, but the available company-type records classify it as a trading entity.

CertificationsThe supplier states that its production base has passed or is certified by GMP, ISO, and HACCP, although the specific certificate numbers, issuing bodies, scope, and validity periods are not provided. This is explicit evidence of claimed certification holding at the production-base level.

Production capacityThe supplier describes an organized pharmaceutical production base and coverage of tablets, capsules, injections, powder for injection, softgels, syrups, ointments, creams, suspensions, infusions, drops, suppositories, and modified-release formulations. Its stated GMP, ISO, and HACCP certifications and one-month stated lead time support production and fulfillment capability, although capacity figures are not provided.

Customization capabilityThe supplier explicitly states that its products can be registered under its QHSK brand or a customer's brand through OEM practice. This directly supports private-label and brand customization capability.